We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FTC and HHS Seek Info on How Industry Middlemen Affect Generic Industry
FTC and HHS Seek Info on How Industry Middlemen Affect Generic Industry
FTC and HHS are jointly seeking more intel on how the practices of two types of pharmaceutical drug middlemen — group purchasing organizations (GPOs) and drug wholesalers — may be contributing to generic drug shortages.